00:36:18 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Akumin Inc
Symbol AKU
Shares Issued 90,998,491
Close 2023-08-08 C$ 0.25
Market Cap C$ 22,749,623
Recent Sedar Documents

Akumin to release Q2 results Aug. 9, host call Aug. 10

2023-08-08 18:22 ET - News Release

An anonymous director reports

AKUMIN TO HOST SECOND QUARTER 2023 FINANCIAL RESULTS CALL ON AUGUST 10, 2023

Akumin Inc. will host a conference call at 8:30 a.m. Eastern Time on Thursday, Aug. 10, 2023, to discuss its second quarter 2023 financial results. The financial results are expected to be available on Wednesday, Aug. 9, 2023.

To listen to the conference call, participants may join by using an appropriate dial-in number or by webcast. A related presentation will be available from Akumin's website. Participants are asked to connect at least 10 minutes prior to the beginning of the call to ensure participation. The webcast archive will be available for 90 days. A replay of the presentation will also be available until Thursday, Aug. 17, 2023, by calling 416-764-8677 or toll-free 1-888-390-0541, using passcode No. 945745.

About Akumin Inc.

Akumin is a national partner of choice for U.S. hospitals, health systems and physician groups, with comprehensive solutions addressing outsourced radiology and oncology service-line needs. Akumin provides: (1) fixed-site outpatient diagnostic imaging services through a network of owned and/or operated imaging locations; and (2) outpatient radiology and oncology services and solutions to approximately 1,100 hospitals and health systems across 48 states. By combining clinical and operational expertise with the latest advances in technology and information systems, Akumin facilitates more efficient and effective diagnosis and treatment for patients and their providers. Akumin's imaging procedures include MRI, CT, positron emission tomography (PET and PET/CT), ultrasound, diagnostic radiology (X-ray), mammography and other interventional procedures. Its cancer care services include a full suite of radiation therapy and related offerings.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.